Amendment Two (2) to the Collaborative Development and Commercialization AgreementDevelopment and Commercialization Agreement • November 8th, 2018 • Achaogen, Inc. • Pharmaceutical preparations
This Amendment 2 (“Amendment”), effective upon the date it is signed by both Parties (“Effective Date”), is by and between Microgenics and Achaogen and issued pursuant to the Collaborative Development and Commercialization Agreement (“Agreement”) dated April 26, 2016 and amended November 29, 2017. The defined terms referenced herein retain their meaning as defined in the Agreement. All amended language in this Amendment has been bolded for ease of reference.
